First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Clinical trial NCT04401020 · TERMINATED
Trial details
- NCT number
- NCT04401020
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2024-03-02
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.